Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Virtual Advanced Course on KRAS Targeting in NSCLC 2022
- Start date
- 28 Nov 2022
- End date
- 29 Nov 2022
- Location
- Virtual, GMT +8
Learning Objectives
- Understanding the function and biology of KRAS in normal and malignant cells
- Gaining insights in the spectrum of KRAS molecular aberrations, platforms and strategies for molecular testing
- In depth discussion of emerging therapeutic strategies and clinical research in KRAS mutated NSCLC
- Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of KRAS G12C inhibition and beyond
Accreditation
The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs:
- Myung-Ju Ahn, Republic of Korea
- Federica Di Nicolantonio, Italy
Supported by
